{
    "type": "ETF",
    "ucits": true,
    "replication_method": "synthetic",
    "leverage": false,
    "derivatives": true,
    "swaps": true,
    "inverse": false,
    "complex_factors": [
        "Synthetic replication using swaps",
        "Counterparty risk exposure",
        "Emerging market complexity"
    ],
    "classification": "complex",
    "supporting_data": "The ETF uses synthetic replication via swaps to track the MSCI Emerging Markets Index, which introduces counterparty risk and complexity beyond direct physical replication. While the fund is UCITS-compliant and has no leverage, the use of derivatives for replication (as confirmed in the factsheet) and exposure to emerging markets (which may involve less liquid and more volatile assets) contribute to its classification as complex under MiFID II. The PRIIPs KID and factsheet confirm the indirect replication method, which is a key indicator of complexity. The fund's risk profile (category 6) and disclosures about counterparty risk further support this classification.",
    "confidence": 90,
    "counter_argument": "The fund is UCITS-compliant and has a straightforward investment objective, which could argue for non-complex classification. However, the synthetic replication method and emerging market exposure override this, as MiFID II prioritizes derivative usage and counterparty risk in complexity assessments.",
    "overriding_reason": "The presence of swaps for replication and emerging market exposure, combined with the fund's risk profile, align with MiFID II's criteria for complexity, despite the fund's UCITS status and lack of leverage."
}